A two-phase case–control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22
2011

Genetic Factors in Colorectal Cancer Risk

Sample size: 2836 publication Evidence: low

Author Information

Author(s): Abulí A, Fernández-Rozadilla C, Giráldez M D, Muñoz J, Gonzalo V, Bessa X, Bujanda L, Reñé J M, Lanas A, García A M, Saló J, Argüello L, Vilella À, Carreño R, Jover R, Xicola R M, Llor X, Carvajal-Carmona L, Tomlinson I P M, Kerr D J, Houlston R S, Piqué J M, Carracedo A, Castells A, Andreu M, Ruiz-Ponte C, Castellví-Bel S

Primary Institution: Hospital Clínic, University of Barcelona

Hypothesis

The study aims to evaluate the genetic susceptibility to colorectal cancer associated with specific chromosomal regions.

Conclusion

Variants in the TOPBP1 and CDV3 genes may influence colorectal cancer risk, but further studies are needed to confirm these findings.

Supporting Evidence

  • Colorectal cancer is the second leading cause of cancer-related death in the Western world.
  • Genetic variants in regions 9q22 and 3q22 were selected based on previous linkage studies.
  • The study included a large cohort of CRC cases and controls from a nationwide initiative.

Takeaway

The study looked at genes that might make people more likely to get colon cancer, but didn't find strong evidence for any specific ones.

Methodology

The study involved a two-phase case-control design with genotyping of 172 SNPs in 84 genes from 1416 colorectal cancer cases and 1424 controls.

Limitations

The sample size may not be large enough to draw definitive conclusions about the genetic variants studied.

Participant Demographics

Participants were from the Spanish population, with a mean age of 70 years at diagnosis.

Digital Object Identifier (DOI)

10.1038/bjc.2011.296

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication